Jinyang Li, PhD (he/him/his)

Innovent Biologics (Suzhou) Co., Ltd.
Suzhou, Jiangsu, China

Principal Scientist, Innovent Biologics

Presentation(s):

• 0082: IBI3011, a Humanized anti-IL1RAP Monoclonal Antibody, Inhibits IL1, IL33, IL36-driven Inflammation Pathway, and Attenuates Inflammation in Preclinical Inflammatory Disease Model

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Innovent Biologics (Suzhou) Co., Ltd.: Employee (Ongoing)

• 0906: Preclinical Characterization of IBI3034, an TACI and BCMA Chimeric Fc Fusion Protein, that Potently Modulates B Lymphocytes and Serum Immunoglobulin for the Treatment of B cell Related Autoimmune Disease

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Innovent Biologics (Suzhou) Co., Ltd.: Employee (Ongoing)